Skip to content

Effect of Stem Cells in Ocular Surface Regeneration following Acute Chemical ocular Burn

The Safety and Efficiency Evaluation of Subconjunctival Injection of Allogenic Umblical Cord Mesenchymal Stem Cells in Ocular Surface Regeneration following Acute Chemical ocular Burn of Individuals Referred to Farabi hospital : Phase I clinical study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231219060471N2
Enrollment
20
Registered
2025-01-25
Start date
2025-02-28
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ocular chemical burn. Chemical burn of cornea and conjunctival sac

Interventions

Intervention 1: Intervention group: Intralimbal injection of bone marrow-derived MSCs with a dose of 5 million in 0.5cc one time 2 weeks after presentation. Intervention 2: Control group: Conventiona

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age between 18 to 65 years Chemical ocular burn At most 2 weeks after the time of occurrence of the chemical ocular burn Burn severity should be grade 5 or 6 according to Dua standard 2001 Patients should enter the study with informed consent and commit to follow-up for at least 3 months

Exclusion criteria

Exclusion criteria: Total blindness (NLP) in either of the eyes Perforated or near-perforated cornea (thinning more than two-thirds of the thickness of the cornea) Indications for other surgery due to complications History of corneal surgery or previous corneal diseases History of ophthalmologic surgery or radiotherapy on the eye Presence of infectious corneal ulcer or endophthalmitis Blepharal pathology including full thickness defect, entropion and ectropion IOP>25mmHg despite taking antiglaucoma drugs Existence of a dangerous underlying disease; Such as uncontrolled blood pressure (>150.95 mmHg), liver or kidney dysfunction Pregnant or lactating woman Neurological disorders

Design outcomes

Secondary

MeasureTime frame
Visual acuity. Timepoint: one month. Method of measurement: Clinical exam.;Conjunctivalization grade. Timepoint: One month. Method of measurement: Slit lamp examination.

Primary

MeasureTime frame
Size of corneal epithelial defect. Timepoint: one week. Method of measurement: Slit lamp examination / Fluorescein staining.;Conjunctival epithelial defect. Timepoint: one week. Method of measurement: Slit lamp examination / Fluorescein staining.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehran Zarei Ghanavati

Tehran University of Medical Sciences

m-zareigh@sina.tums.ac.ir+98 21 5542 1080

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026